YAP-Hippo signalling downstream of leukemia inhibitory factor receptor: implications for breast cancer
Abstract:
The proto-oncogenes YAP and TAZ have previously gained much attention as downstream effectors of Hippo tumour suppressor signalling. While the regulation of YAP/TAZ by MST/LATS kinases is reasonably well understood, the nature of factors functioning upstream of MST/LATS is yet to be elucidated in detail. A recent paper by Ma and co-workers defines a novel role for leukemia inhibitory factor receptor (LIFR) signalling upstream of the Hippo-YAP pathway in breast cancer metastasis. Moreover, a whole genome in vivo RNA interference screen by Lippmann and colleagues identified LIFR as a breast tumour suppressor. Here, we discuss the implications of these studies for breast cancer research and treatment.
Insights
Leukemia inhibitory factor receptor (LIFR) signaling acts upstream of the Hippo-YAP pathway, impacting breast cancer metastasis. LIFR functions as a breast tumor suppressor, offering new research and treatment avenues.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Yeast and TAZ are key downstream effectors of the Hippo tumor suppressor pathway.
- MST/LATS kinases regulate YAP/TAZ, but upstream factors remain unclear.
- The Hippo pathway is crucial in regulating organ size and suppressing tumors.
Purpose of the Study:
- To elucidate the upstream regulators of the Hippo-YAP pathway.
- To define the role of leukemia inhibitory factor receptor (LIFR) signaling in breast cancer metastasis.
- To investigate LIFR as a potential breast tumor suppressor.
Main Methods:
- In vivo RNA interference screening.
- Analysis of signaling pathways in breast cancer models.
- Literature review and discussion of recent findings.
Main Results:
- LIFR signaling identified upstream of the Hippo-YAP pathway.
- LIFR demonstrated a role in suppressing breast cancer metastasis.
- Whole genome screening identified LIFR as a breast tumor suppressor.
Conclusions:
- LIFR is a novel regulator upstream of the Hippo-YAP pathway.
- LIFR has significant implications for understanding and treating breast cancer metastasis.
- Targeting LIFR may offer new therapeutic strategies for breast cancer.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
07:16Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor
Published on: September 13, 2018
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Angiogenesis and Blood Supply
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
